News and Announcements
BPS Features in CommSec Executive Series
- Published April 01, 2016 2:26PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
31st March 2016, ASX Announcement
BPS Technology Limited (ASX: BPS) last month announced another successful half-year with an increase of 4% in its EBITDA, 7.3% increase in net profit and an increase in earnings per share of 7.2%.
Please see below for a short interview where Trevor Dietz, CEO of BPS, talks to Tom Piotrowski of CommSec about the highlights of the first half of the 2016 financial year.
ABOUT BPS TECHNOLOGY
BPS Technology Limited (ASX: BPS) provides technology and payment platforms centred on SME’s. It is a profitable business operates in eight countries, capitalising on a number of significant growth opportunities.
BPS operates three highly complementary and scalable businesses – Bartercard, bucqi and TESS.
Bartercard operates the world’s largest trade exchange. It allows SME’s to conduct $600m of additional business without the use of cash.
To watch the video please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
